Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2023 05:00 ET | Source: Alvotech

Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)

Polifarma will commercialize AVT06, a proposed biosimilar to Eylea® (aflibercept), in Turkey REYKJAVIK, Iceland, May 10, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company...
May 05, 2023 09:00 ET | Source: Alvotech

Alvotech S.A. Annual General Meeting to be held June 6, 2023

The Annual General Meeting of Alvotech S.A. will be held on Tuesday 6 June 2023, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg,...
May 05, 2023 09:00 ET | Source: Alvotech

Aðalfundur Alvotech S.A. boðaður 6. júní 2023

Aðalfundur Alvotech S.A. verður haldinn þriðjudaginn 6. júní 2023, kl. 09.00 CEST á skrifstofu Arendt & Medernach S.A að 41A Avenue John F. Kennedy, L-1855 Lúxemborg. Drög af dagskrá fundarins...
May 04, 2023 05:00 ET | Source: Alvotech

Alvotech Initiates Confirmatory Patient Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®

The clinical study will compare AVT05 and Simponi® in patients with moderate to severe rheumatoid arthritis REYKJAVIK, Iceland, May 04, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global...
May 04, 2023 05:00 ET | Source: Alvotech

Alvotech Initiates Confirmatory Patient Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®

The clinical study will compare AVT05 and Simponi® in patients with moderate to severe rheumatoid arthritis Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and...
May 04, 2023 05:00 ET | Source: Alvotech

Alvotech hefur klíníska rannsókn á AVT05, fyrirhugaðri líftæknilyfjahliðstæðu við Simponi® og Simponi Aria®

Rannsóknin mun bera saman AVT05 og Simponi® í sjúklingum með meðallagi alvarlega og alvarlega liðagigt Alvotech (NASDAQ: ALVO) hefur hafið klíníska rannsókn á AVT05, fyrirhugaðri...
May 03, 2023 09:00 ET | Source: Alvotech

Alvotech birtir uppgjör fyrsta ársfjórðungs 2023 þann 18. maí nk. og heldur kynningarfund 19. maí nk. kl. 12 að íslenskum tíma

Alvotech (NASDAQ: ALVO) mun birta uppgjör fyrsta ársfjórðungs 2023 eftir lokun markaða í Bandaríkjunum, fimmtudaginn 18. maí 2023. Þá mun Alvotech halda kynningarfund fyrir fjárfesta í beinu streymi...
May 03, 2023 09:00 ET | Source: Alvotech

Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on May 19, 2023 at 8:00 am ET

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results...
May 03, 2023 09:00 ET | Source: Alvotech

Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on May 19, 2023 at 8:00 am ET

REYKJAVIK, Iceland, May 03, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
April 19, 2023 17:30 ET | Source: Alvotech

Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer

REYKJAVIK, Iceland, April 19, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...